TNF and post-transplant lymphoproliferative disease: The remaining investigated TNF promoter polymorphisms, at nucleotide positions −857(C/T), −307(G/A) and −237(G/A), showed no differences in allele or genotype frequency between transplant patients with or without PTLD or healthy controls (Table 2).